UBA1 and myelodysplastic syndrome: This necessitates the emphasis of UBA1 somatic mutations in the definition of VEXAS rather than defining the disease based on the co-existence of inflammatory symptoms and cytopenias, which can be observed in patients with MDS harboring other mutations [23, 50, 51] and chromosomal abnormalities [52, 53].